Modified Botox found to give long-term pain relief after nerve injury without side effects

A team of scientists from the Universities of Sheffield, Reading and University College London (UCL) and US-based biopharmaceutical company Neuresta have created a new, elongated botulinum neurotoxin which can alleviate chronic pain without risk of paralysis or addiction.

Leave A Comment

Your email address will not be published. Required fields are marked *